Partners

Beneficiaries

Helmholz Munich (coordinator), Germany

AstraZeneca AB, Sweden

Bayer Aktiengesellschaft, Germany

Pfizer Pharma GmbH, Germany (since 01/12/2022)

Janssen Pharmaceutica NV , Belgium

Enamine Limited Liability Company, Ukraine

Aalto University, Finland

Freie Universität Berlin, Germany

Katholieke Universiteit Leuven, Belgium

Johannes Kepler Universität Linz, Austria

Scuola Universitaria Professionale della Svizzera Italiana, Switzerland

TU Dortmund, Germany (01/2021 - 19/05/2022)

Johannes Gutenberg-Universität Mainz  (since 01/03/2022)

Universiteit Leiden, Netherlands

Université du Luxembourg, Luxembourg

University of Vienna, Austria

Universitat Pompeu Fabra, Spain

Vancouver Prostate Center, University of British Columbia, Canada (own contribution)

Associated Partners

Technical University of Munich, Germany

University of Southern Switzerland

Ascenion GmbH, Germany

Novartis Institutes for Biomedical Research, Switzerland

University of North Carolina at Chapel Hill, USA

La Trobe University, Australia

Bar-Ilan University, Israel

Guangzhou Regenerative Medicine and Health-Guangdong Laboratory, Centre of Chemistry and Chemical Biology, China

Instituto di Ricerche Farmacologiche "Mario Negri", Italy

Max Planck Institute of Molecular Physiology, Germany

Beijing University of Chemical Technology, China

Chelonia SA, Switzerland